Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics
BPGbio, a leading AI-powered biopharma that focuses on oncology, neurology, and rare diseases, today announced […]
Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
Epic Sciences, a privately held diagnostics company, has completed a $24 million Series G which […]
MOLLI Surgical Launches Breakthrough Products to Simplify Breast Cancer Surgery and Deliver a Better Patient Experience
MOLLI Surgical, the company that is pushing the boundaries of precision surgery for breast cancer, […]
Novartis Trial Shows Benefit in Patients with Breast Cancer
Novartis today announced positive topline results from an interim analysis of NATALEE, a Phase III […]
Cantargia Treats First Triple-Negative Breast Cancer Patient in Randomized Phase II Part of TRIFOUR Trial
Cantargia today reported that, following positive results in the lead-in phase of the clinical phase […]
Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program
Radiology Imaging Associates (RIA), a division of RadNet, has announced that it has started the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more